Stonegate Investment Group »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Stonegate Investment Group

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Stonegate Investment Group from 13F filings

Historical chart of Stonegate Investment Group investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Stonegate Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Stonegate Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 13k 1.64

More positions owned by Stonegate Investment Group

Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Wal-Mart Stores (WMT)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Chevron Corporation (CVX)
Phillips 66 (PSX)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Cisco Systems (CSCO)
Home Depot (HD)
Johnson & Johnson (JNJ)
Palo Alto Networks (PANW)

View all positions for Stonegate Investment Group

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
MacKay Shields
LMR Partners
Parallax Volatility Advisers
Morgan Stanley
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1